Loss of blood flow (ischemia) in the liver impairs the oxygenation of tissues and organs. The reperfusion that occurs to prevent hypoxic cellular damage after ischemia also damages the liver. Causes of liver I/R injury include long-term surgical liver resection (eg, Pringle maneuver), sepsis, trauma, shock, bleeding, heart failure, respiratory failure, or liver transplantation
1,11. Liver I/R damage can cause liver dysfunction and even failure, and it can also lead to failure in distant organs such as the heart, lung, and kidney
1,11. Liver I/R injury is a therapeutic problem that needs an urgent solution because it affects the prognosis of the disease, the success rate of the surgical procedure and patient survival
12.
It is thought that the early phase of liver I/R injury is caused by the change in the redox state of the liver tissue, while the late phase is caused by the production of cytokines and chemokines and the infiltration of leukocytes into the liver tissue1. Depending on I/R, metabolic acidosis, increase in intracellular calcium, mitochondrial damage, Kupffer cell activation, oxidative stress develops, inflammatory response is activated and eventually necrotic or apoptotic cell death occurs11.
Estrogens are steroid sex hormones that are particularly effective in the female reproductive system13. They are also necessary for the development and function of the male reproductive system14. They also play an important role in non-reproductive biological functions and pathological processes, cell proliferation, growth, migration, aging, and regulation of many disease states14-16. In particular, 17β-estradiol, which is the dominant and strongest endogenous estrogen, plays a role in reducing the incidence of many diseases in preme-nopausal women14. Estrogens exert their effects through the classical and at the same time nuclear estrogen receptors ERα and ERβ and besides these receptors, GPER-114-16.
GPER-1, also known as G protein-coupled receptor 30 (GPR30) or 7-transmembrane domain G protein-associated receptor (GPCR), is a novel membrane-anchored estrogen receptor capable of inducing rapid kinase signaling in a variety of cells12,16-19 . GPER-1 can be activated by many stimuli, including estrogen12. GPER-1 is implicated in both transcriptional regulation and rapid, non-genomic signaling. GPER-1 is expressed everywhere in the body14-16. GPER plays a role in reproductive, nervous, endocrine, immune and cardiovascular systems and in various diseases including cancer14. In addition, GPER-1 signal has been shown to have a protective effect aga-inst I/R damage 19.
Estrogens show rapid effects such as calcium influx or nitric oxide (NO) release via GPER13. NO is a short-lived gas that plays a role in protection from atherosclerosis and inflammation20. Reduction in NO levels is one of the most important factors in the pathogenesis of I/R injury. Exogenous NO is effective in reducing oxidative stress, cytokine release, leukocyte endothelial adhesion and hepatic apoptosis21. In the study by Meyer et al20, deletion of GPER increased the progression of atherosclerosis and decreased vascular NO bioactivity in mice with intact ovaries. G-1 is the selective agonist of GPER, and G15 is the selective antagonist14. Chronic treatment with G1 reduced postmenopausal atherosclerosis and inflammation without uterotrophic effects20. It was observed by Deschamps et al 6that G1 administration after myocardial infarction in female and male rodents reduces the damage and abnormal contractions caused by reperfusion. Weil et al22 showed that G1 administration reduced the levels of proinflammatory cytokines.
Opening the mitochondrial permeability pore (mPTP) after I/R is effective in cell death. mPTP remains closed in myocardial ischemia, but in this case, these pores open shortly after reperfusion with the excessive increase in Ca2+ in mitochondria, oxidative stress and decrease in the amount of ATP. After I/R, infarct size was significantly reduced in G1-treated hearts and the Ca+2 load needed to induce mPTP opening increased compared with controls. Based on these results, it is stated that GPER activation provides a cardioprotective effect after I/R by inhibiting mPTP opening23.
The clinical role and mechanism of GPER in hepatic I/R is still unclear12. Estrogen has been shown to significantly reduce liver damage after I/R 24. In the study by Li et al25, it was seen that estrogen has a protective effect on the mouse hepatic I/R model and administration of G15, a specific antagonist of GPER, before estrogen prevents this beneficial effect. 17β-estradiol (E2) is effective in cell cycle induction, hepatocyte proliferation and increase in liver size in larval zebrafish. GPER-1 mediates these effects. It is stated that in vivo chemical inhibition of GPER-1 in males significantly reduces E2-mediated tumor progression after chemical carcinogenesis26. Again, in the study of Kandemir et al16, GPER levels showed high expression in patients with chronic hepatitis B.
A prominent feature of liver I/R injury is an excessive inflammatory response. NOD-, LRR- and pyrin domain containing 3 (NLRP3) plays a role in I/R injury by activating inflammation as an important pattern recognition receptor of innate immunity. G1 pretreatment or NLRP3 silencing in hepatic I/R injury improved histological changes and hepatocyte apoptosis12. Again, in the study of Lin et al27, it was observed that estrogen significantly inhibited apoptosis caused by hepatic I/R damage and had a protective effect on liver I/R damage27.
Rheum ribes L. is a perennial herbaceous plant that grows in temperate and subtropical climates, grows on rocks and stony areas, 40–150 cm tall, blooms in May-June28. Fresh stems and petioles are consumed as vegetables, and the roots are used in the treatment of many diseases29. Rheum ribes L. has an important antioxidant effect with its content, and the molecules it contains vary according to the region where it grows and the part of the plant used in the treatment30,31. In the study of Bakir et al32 it was observed that Rheum ribes L. had a protective effect on CCl4-induced liver toxicity.
The significant increase in GPER-1 levels in the I/R+Rheum ribes L. group compared to the sham and I/R groups in our current study suggests that Rheum ribes L. is effective in GPER-1 expression. However, the significant decrease observed in GPER-1 levels in the I/R+Rheum ribes L. group compared to the control group shows that the surgical intervention itself is also effective in reducing GPER-1 levels and that the treatment cannot provide a complete recovery. In this case, further studies should be conducted to determine whether a full recovery in GPER-1 levels can be achieved by readjusting the dose of Rheum ribes L.
Phytoestrogens show their physiological effects by activating ERα and ERβ as well as GPER14. Since it is known that GPER-1 is activated by various phytoestrogens with antioxidant effect and Rheum ribes L. also contains molecules with antioxidant activity, based on the histopathological data we obtained from our study, we think that Rheum ribes L. not only increases GPER-1 levels, but also has a protective effect against liver I/R damage by activating GPER-1.
The limitation of this study is that there is not enough literature information about the effect of Rheum ribes L. on liver I/R damage or GPER-1 levels. This situation makes it difficult for us to interpret the mechanisms that Rheum ribes L. can use in the effect of GPER-1 levels in I/R injury. Again, as far as we know, the region where the plant grows and the part used for treatment cause it to contain different molecules. In our study, plants were collected from a single site and we do not know which of the molecules found in the stem of the plant is more effective in increasing GPER-1 levels. This is another limitation.